Charles River Laboratories | CRL - Trade Debtors

Stock Price
178.49
Daily Change
3.03 1.73%
Monthly
-17.70%
Yearly
7.97%
Q1 Forecast
163.68

Charles River Laboratories reported $1.43B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.52B 34M Dec/2025
Align Technology USD 1.1B 2.38M Dec/2025
Bio-Rad Laboratories USD 464.7M 5.2M Sep/2025
Bruker USD 544.9M 6M Dec/2025
Cardinal Health USD 13.66B 108M Dec/2025
Charles River Laboratories USD 1.43B 54.59M Dec/2025
Cigna USD 31.71B 3.74B Sep/2025
Concord Medical Services Hldg CNY 98.11M 32.16M Jun/2023
CVS Health USD 39.78B 4.08B Dec/2025
Danaher USD 3.91B 762M Dec/2025
Dentsply International USD 688M 34M Dec/2025
Elevance Health USD 21.54B 807M Dec/2025
Galapagos EUR 77.67M 145.85M Sep/2025
Hologic USD 584.2M 16.6M Dec/2025
Humana USD 3.27B 586M Dec/2025
Illumina USD 854M 125M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Intrexon USD 1.02M 559K Jun/2024
IQVIA Holdings USD 3.43B 113M Dec/2025
Laboratory Of America USD 2.26B 4.5M Dec/2025
Lonza CHF 1.78B 55M Dec/2025
McKesson USD 28.21B 73M Dec/2025
Merck EUR 4.73B 182M Sep/2025
Mettler Toledo International USD 778.24M 90.98M Dec/2025
Novartis USD 8.98B 192M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Quest Diagnostics USD 1.41B 48M Dec/2025
Revvity USD 744.67M 64.41M Dec/2025
Thermo Fisher Scientific USD 8.9B 11M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
UnitedHealth USD 23.02B 346M Dec/2025
Veradigm USD 234.48M 18.71M Sep/2022
Waters USD 828.84M 80.32M Dec/2025
West Pharmaceutical Services USD 574.4M 50.6M Dec/2025